Manchester Financial Inc Amgen Inc Transaction History

Manchester Financial Inc

$380 Million
Q2 2024

A detailed history of Manchester Financial Inc transactions in Amgen Inc stock. As of the latest transaction made, Manchester Financial Inc holds 3,715 shares of AMGN stock, worth $1.19 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

3,715

Previous 3,573 3.97%

Holding current value

$1.19 Million

Previous $1.02 Million 14.29%

% of portfolio

0.31%

Previous 0.27%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $37,310 - $45,342	142 Added 3.97%	3,715 $1.16 Million
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $6,721 - $8,114	-25 Reduced 0.69%	3,573 $1.02 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 0.33%	3,598 $1.04 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $4,373 - $5,429	-20 Reduced 0.55%	3,586 $963,000
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $229,268 - $271,105	-1,070 Reduced 22.88%	3,606 $800,000
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $4,064 - $4,953	18 Added 0.39%	4,676 $1.13 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $35,270 - $44,815	154 Added 3.42%	4,658 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $42,198 - $47,592	-188 Reduced 4.01%	4,504 $1.02 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $4,604 - $5,093	21 Added 0.45%	4,692 $1.14 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $7,159 - $8,193	-36 Reduced 0.76%	4,671 $1.05 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $824,456 - $965,950	-3,884 Reduced 45.21%	4,707 $1 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $107,913 - $119,722	-462 Reduced 5.1%	8,591 $2.09 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $5,103 - $5,947	23 Added 0.25%	9,053 $2.25 Million
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $7,573 - $9,018	-35 Reduced 0.39%	9,030 $2.08 Million
Q3 2020 Oct 15, 2020	SELL	$234.65 - $260.95 $23,230 - $25,834	-99 Reduced 1.08%	9,065 $2.3 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $14,943 - $19,819	-82 Reduced 0.89%	9,164 $1.86 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $4,919 - $6,323	-26 Reduced 0.28%	9,246 $2.23 Million
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $673,805 - $807,359	3,870 Added 71.64%	9,272 $1.79 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $7,334 - $8,598	44 Added 0.82%	5,402 $995,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $158,261 - $178,395	875 Added 19.52%	5,358 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $799,767 - $933,584	4,483 New	4,483 $873,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Financial Inc with notifications on news.

Account

Manchester Financial Inc Amgen Inc Transaction History